• Explore /
  • Poster
  • / An interim evaluation of efficacy and safety of the combination of panitumumab, gemcitabine, and irinotecan in patients with advanced or metastatic cholangiocarcinoma: A phase II study.

An interim evaluation of efficacy and safety of the combination of panitumumab, gemcitabine, and irinotecan in patients with advanced or metastatic cholangiocarcinoma: A phase II study.

Abstract Poster

Authors

null

Weijing Sun

Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Weijing Sun , Davendra Sohal , Kristine Mykulowycz , Ursina R. Teitelbaum , Nevena Damjanov , Bruce J. Giantonio , Mary Carberry , Paul Stephen Wissel , Mona Jacobs-Small , Peter James O'Dwyer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT00948935

Citation

J Clin Oncol 30, 2012 (suppl 4; abstr 328)

DOI

10.1200/jco.2012.30.4_suppl.328

Abstract #

328

Poster Bd #

E12

Abstract Disclosures

Similar Posters

First Author: Radoslav Chekerov

First Author: Bhargavi Pulluri

Poster

2018 Gastrointestinal Cancers Symposium

A phase 2 study of s-1 plus leucovorin in patients with untreated advanced cholangiocarcinoma (CCA).

A phase 2 study of s-1 plus leucovorin in patients with untreated advanced cholangiocarcinoma (CCA).

First Author: Suebpong Tanasanvimon

First Author: Aarti K. Bhatia